These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35098258)

  • 1. Considerations before the application of 5-hydroxymethylation levels of long non-coding RNAs for non-invasive cancer diagnosis.
    Zhang Z; Zeng C; Zhang W
    Extracell Vesicles Circ Nucl Acids; 2022; 3(1):10-13. PubMed ID: 35098258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genome-wide 5-hydroxymethylation of blood samples stored in different anticoagulants: opportunities for the expansion of clinical resources for epigenetic research.
    Gao L; Zhang Z; Cui XL; West-Szymanski D; Ye C; He C; Zhang W; Bissonnette M
    Epigenetics; 2023 Dec; 18(1):2271692. PubMed ID: 37898998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning identifies cell-free DNA 5-hydroxymethylation biomarkers that detect occult colorectal cancer in PLCO Screening Trial subjects.
    West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; Moore M; He C; Bissonnette M; Zhang W
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines.
    Cai Q; Zhang Z; Cui X; Zeng C; Cai J; Cai J; Wu K; Zhang X; Shi Y; Arvanitakis Z; Bissonnette MA; Chiu BC; Cheng SY; He C; Zhang W
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37387524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential.
    Yang Y; Zeng C; Yang K; Xu S; Zhang Z; Cai Q; He C; Zhang W; Liu SM
    Extracell Vesicles Circ Nucl Acids; 2022; 3(1):49-60. PubMed ID: 35342902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.
    Cai J; Zeng C; Hua W; Qi Z; Song Y; Lu X; Li D; Zhang Z; Cui X; Zhang X; Yang Z; Zhang J; Quan K; Zhu W; Cai J; He C; Cheng SY; Zhang W; Mao Y
    Neurooncol Adv; 2021; 3(1):vdab049. PubMed ID: 34151267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.
    Li S; Wang Y; Wen C; Zhu M; Wang M; Cao G
    Front Cell Dev Biol; 2022; 10():845641. PubMed ID: 35399499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
    Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
    Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.
    Hu H; Shu M; He L; Yu X; Liu X; Lu Y; Chen Y; Miao X; Chen X
    Br J Cancer; 2017 Feb; 116(5):658-668. PubMed ID: 28141796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
    Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
    Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma.
    Zeng C; Zhang Z; Wang J; Chiu BC; Hou L; Zhang W
    Epigenomes; 2019 Sep; 3(3):. PubMed ID: 31413874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
    Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
    J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
    Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
    Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer.
    Zhang J; Han X; Gao C; Xing Y; Qi Z; Liu R; Wang Y; Zhang X; Yang YG; Li X; Sun B; Tian X
    Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):187-199. PubMed ID: 30010036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
    Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
    Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA.
    Zhang Z; Pi X; Gao C; Zhang J; Xia L; Yan X; Hu X; Yan Z; Zhang S; Wei A; Guo Y; Liu J; Li A; Liu X; Zhang W; Liu Y; Xie D
    Transl Oncol; 2023 Aug; 34():101694. PubMed ID: 37209526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.